WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002026804) 84241, A HUMAN RING FINGER FAMILY MEMBER AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/026804    International Application No.:    PCT/US2001/029968
Publication Date: 04.04.2002 International Filing Date: 25.09.2001
Chapter 2 Demand Filed:    22.04.2002    
IPC:
C07K 14/47 (2006.01)
Applicants: MILLENNIUM PHARMACEUTICALS, INC. [US/US]; 75 Sidney Street, Cambridge, MA 02139-4169 (US) (For All Designated States Except US).
KAPELLER-LIBERMANN, Rosana [BR/US]; (US) (For US Only)
Inventors: KAPELLER-LIBERMANN, Rosana; (US)
Agent: MILLENNIUM PHARMACEUTICALS, INC.; Legal-Intellectual Property, 40 Landsdowne Street, Cambridge, MA 02139 (US)
Priority Data:
60/235,032 25.09.2000 US
Title (EN) 84241, A HUMAN RING FINGER FAMILY MEMBER AND USES THEREOF
(FR) 84241, NOUVEAU MEMBRE HUMAIN DE LA FAMILLE RING FINGER ET UTILISATION DE CELUI-CI
Abstract: front page image
(EN)The invention provides isolated nucleic acids molecules, designated 84241 nucleic acid molecules, which encode novel RING finger members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 84241 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 84241 gene has been introduced or disrupted. The inventioln still further provides isolated 84241 proteins, fusion proteins, antigenic peptides and anti-84241 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
(FR)L'invention concerne des molécules d'acides nucléiques isolées, appelées molécules d'acide nucléique 84241, codant des nouveaux membres RING finger. L'invention concerne également des molécules d'acide nucléique antisens, des vecteurs d'expression de recombinaison renfermant des molécules d'acide nucléique 84241, des cellules hôtes dans lesquelles ces vecteurs ont été introduits, ainsi que des animaux transgéniques non humains dans lesquels un gène 84241 a été introduit ou fragmenté. L'invention concerne en outre des protéines 84241 isolées, des protéines de fusion, des peptides antigéniques et des anticorps anti-84241. L'invention concerne enfin des méthodes diagnostiques mettant en oeuvre des compositions selon l'invention.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)